[go: up one dir, main page]

CA2767614A1 - Schemas posologiques de l'acide fusidique pour le traitement d'infections bacteriennes - Google Patents

Schemas posologiques de l'acide fusidique pour le traitement d'infections bacteriennes Download PDF

Info

Publication number
CA2767614A1
CA2767614A1 CA2767614A CA2767614A CA2767614A1 CA 2767614 A1 CA2767614 A1 CA 2767614A1 CA 2767614 A CA2767614 A CA 2767614A CA 2767614 A CA2767614 A CA 2767614A CA 2767614 A1 CA2767614 A1 CA 2767614A1
Authority
CA
Canada
Prior art keywords
staphylococus
infection
loading dose
hours
fusidic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2767614A
Other languages
English (en)
Other versions
CA2767614C (fr
Inventor
Ronald Jones
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arrevus Inc
Original Assignee
Cempra Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cempra Pharmaceuticals Inc filed Critical Cempra Pharmaceuticals Inc
Publication of CA2767614A1 publication Critical patent/CA2767614A1/fr
Application granted granted Critical
Publication of CA2767614C publication Critical patent/CA2767614C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2767614A 2009-07-13 2009-07-13 Schemas posologiques de l'acide fusidique pour le traitement d'infections bacteriennes Active CA2767614C (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2009/050353 WO2011008193A1 (fr) 2009-07-13 2009-07-13 Schémas posologiques de l’acide fusidique pour le traitement d’infections bactériennes

Publications (2)

Publication Number Publication Date
CA2767614A1 true CA2767614A1 (fr) 2011-01-20
CA2767614C CA2767614C (fr) 2019-01-15

Family

ID=43449613

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2767614A Active CA2767614C (fr) 2009-07-13 2009-07-13 Schemas posologiques de l'acide fusidique pour le traitement d'infections bacteriennes

Country Status (2)

Country Link
CA (1) CA2767614C (fr)
WO (1) WO2011008193A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2529817C (fr) 2003-03-10 2013-02-12 Optimer Pharmaceuticals, Inc. Nouveaux agents antibacteriens
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
WO2010048600A1 (fr) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Procédés de traitement de maladies résistantes en utilisant des macrolides contenant du triazole
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
EP2571506B1 (fr) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Procédés de préparation de macrolides et de kétolides et d'intermédiaires de ceux-ci
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (fr) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Formulations parentérales pour l'administration d'antibiotiques macrolides
EP2968801B1 (fr) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Procédés pour traiter des maladies respiratoires et formulations pour la mise en oeuvre de ceux-ci
MX356772B (es) 2013-03-15 2018-06-13 Cempra Pharmaceuticals Inc Procesos convergentes para la preparacion de agentes antibacterianos macrolidos.
US9345717B2 (en) 2013-09-25 2016-05-24 Zavante Therapeutics, Inc. Method for improving drug treatments in mammals
CN116650399B (zh) * 2023-04-13 2025-09-05 福元药业有限公司 一种夫西地酸乳膏及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1040363B (en) * 1998-09-25 2007-01-26 Cubist Pharmaceuticals Llc Use of daptomycin
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition

Also Published As

Publication number Publication date
CA2767614C (fr) 2019-01-15
WO2011008193A1 (fr) 2011-01-20

Similar Documents

Publication Publication Date Title
CA2767614C (fr) Schemas posologiques de l'acide fusidique pour le traitement d'infections bacteriennes
US8450300B2 (en) Fusidic acid dosing regimens for treatment of bacterial infections
US8420592B2 (en) Methods of treatment using single doses of oritavancin
US8247394B2 (en) Methods of treating urethritis and related infections using fusidic acid
US20130164351A1 (en) Methods of treating bacterial infections through pulmonary delivery of fusidic acid
EP2424559B1 (fr) Procédés de traitement d'infections bactériennes à l'aide d'oritavancine
US9775878B2 (en) Methods for treating bacterial infections using oritavancin and polymyxins
AU2013202360B2 (en) Methods of treatment using single doses of oritavancin
US8916543B1 (en) Inhibitors of alpha-toxin
US20190388437A1 (en) Compositions and methods for treating bone and joint infections
JP2020508299A (ja) 非ヒト動物におけるグラム陽性菌及びグラム陰性菌に起因する疾患に対するリソバクチンとアミノグリコシド類の組み合わせ

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140623